Gwendolyn Schreffler's most recent trade in Core Laboratories N.V. was a trade of 21,418 Performance Shares done . Disclosure was reported to the exchange on Feb. 16, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Core Laboratories NV | Gwendolyn Schreffler | SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 21,418 | 21,418 | - | - | Performance Shares | |
| Core Laboratories NV | Gwendolyn Schreffler | SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 12,000 | 0 | - | - | Performance Shares | |
| Core Laboratories NV | Gwendolyn Schreffler | SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 12,000 | 19,783 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories NV | Gwendolyn Schreffler | SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.27 per share. | 31 Dec 2022 | 4,722 | 15,061 (0%) | 0% | 20.3 | 95,715 | Common Shares |
| Core Laboratories NV | Gwendolyn Schreffler | SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 17,588 | 17,588 | - | - | Performance Shares | |
| Core Laboratories NV | Gwendolyn Schreffler | SVP | Other type of transaction at price $ 0.00 per share. | 18 Jun 2021 | 2,896 | 4,933 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories NV | Gwendolyn Schreffler | SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 13,810 | 13,810 | - | - | Performance Shares |